Pharmacoepidemiologic usage analysis of neuroleptics for treating paranoid schizophrenia in psychiatry hospital

Abstract

During pharmacotherapy with neuroleptics of paranoid schizophrenia patients there had been studied retrospectively and perspectively frequency and expressiveness of side effects. There was determined a correlation between neuro-motor reaction expressiveness of neuroleptics and sex, age and time of intake. The obtained results can be very useful to a practioner for his/ her rational usage of psychotropic medications, removal of neuro- motor reaction and making decision in continuation of neuroleptic therapy.

Keywords

Bekhterev neurology archive

References

[1] Тиганов А.С. Руководство по психиатрии. —2000. —Т. 1.

[2] Шакиров И.А., Волынец С.И., Костейко Л.А. Комбинированное лечение больных эглонилом и лепонексом в условиях дневного психиатрического стационара / Новые методы диагностики и лечения психических заболеваний: сб. науч. тр. / Белорус. респ. науч. о-во психиатров, Респ. клинич. психиатр. больница МЗ БССР. — Минск, 1989. — С.178—180.

[3] American Psychiatric Association (1997), Practice guideline for the treatment of patients with schizophrenia. // Am. J. Psychiatry. Vol. 154(4). — P. 1—63. Prescription des neuroleptiques. In Recommendations de Pratique Clinique (tome 2) ANDEM. — Paris, 1994 — P. 211—242.

[4] Findling R.L. Paediatric psychopharmacology: closing the gap between science and practice (In Process Citation). Expert Opin Pharmacother. — 2001 Apr. — Vol. 2(4). — P. 523—525.

[5] Gross G., Huber G. // Psychopathology. — 1986. — Vol. 19(1). — P. 50—59.

[6] Jacobsen L.K, Rapoport J.L (1998) // J. Child. Psychol. Psychiatry. — Vol. 39. P.101—113.

[7] Jeste D.V., Lacro J.P. et al. // Am. J. Psychiatry. — 1999. — Vol. 156(2).

[8] Joy C.B., Adams C.E., Lawrie S.M. Haloperidol versus placebo for schizophrenia (Cochrane Review). In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software.

[9] Krieger S., Lis S., Gallhofer B. // Acta Psychiatr. Scand. Suppl. — 2001. — Vol. (408). — P. 18—27.

[10] Lees A.J. MD, MRCP Consultant Neurologist National Hospitals for Nervous Diseases University College Hospital end Whittington Hospital, London U.K. “Tics and Related Disorders. — 1985.

[11] Muscettola G., Casiello M., Bollini P., Sebastiany G., Pampallona S., Tognoni G. //Acta Psychiatr. Scand. — 1987. — Vol. 75 —P. 55—61.

[12] McGrath J.J., Soares KVS Benzodiazepines for neuroleptic-induced tardive dyskinesia. The Cochrane Library. — 1999. — Issue 4. — P. 1—2.

[13] McGrath J.J., Soares K.V. Benzodiazepines for neuroleptic-induced tardive dyskinesia. Cochrane Database Syst Rev. — 2000(2).

[14] McClellan J.M., Werry J.S., Ham M. // J. Autism. Dev. Disord. — 1993. — Vol. 23. — P. 243—262.

[15] Strom B.L. Pharmacoepidemiology / (Ed.) - 2nd ed. — N.-Y., 1994.

RIGHTS & PERMISSIONS

Kuchaeva A.V., Ziganshina L.E., Yakhin K.K., Minnetdinova L.M., Gatin F.F., Mikhailova E.B.